sever
month
newli
identifi
ill
term
sever
acut
respiratori
syndrom
sar
spread
rapidli
world
new
coronaviru
sarscov
identifi
sar
pathogen
trigger
sever
pneumonia
acut
often
lethal
lung
failur
moreov
among
infect
individu
influenza
spanish
flu
emerg
new
respiratori
diseas
virus
caus
high
lethal
result
acut
lung
failur
cell
line
angiotensinconvert
enzym
identifi
potenti
sarscov
receptor
high
lethal
sarscov
infect
enorm
econom
social
impact
fear
renew
outbreak
well
potenti
misus
virus
biolog
weapon
make
paramount
understand
pathogenesi
sarscov
provid
first
genet
proof
crucial
sarscov
receptor
vivo
spike
mice
worsen
acut
lung
failur
vivo
attenu
block
reninangiotensin
pathway
result
provid
molecular
explan
sarscov
infect
caus
sever
often
lethal
lung
failur
suggest
ration
therapi
sar
possibl
respiratori
diseas
virus
recent
identifi
function
sar
coronaviru
receptor
cell
line
possibl
second
receptor
lsign
also
identifi
vitro
studi
thu
known
whether
inde
crucial
sarscov
infect
vivo
address
question
genet
infect
knockout
control
wildtyp
mice
sarscov
report
previous
sarscov
infect
wildtyp
mice
result
viral
replic
lung
recoveri
larg
amount
tissu
cultureinfecti
dose
infect
cell
monolay
tcid
per
gram
lung
tissu
infecti
viru
fig
knockout
mice
low
quantiti
infecti
sarscov
viru
could
recov
tcid
per
gram
lung
tissu
fig
copi
number
sarscov
spike
rna
greatli
reduc
fig
sarscov
infect
mice
associ
develop
mild
patholog
chang
lung
fig
moreov
patholog
alter
lung
reduc
mutant
mice
compar
wildtyp
mice
fig
data
provid
first
genet
proof
inde
crucial
vivo
sar
receptor
requir
effect
replic
infecti
sarscov
recent
shown
reninangiotensin
system
crucial
role
sever
acut
lung
injuri
sarscov
receptor
protect
role
acut
lung
failur
fig
notabl
experiment
sarscov
infect
wildtyp
mice
vivo
result
consider
reduc
express
lung
fig
suggest
reduc
express
might
role
sarscovmedi
sever
acut
lung
patholog
contrast
ace
lung
express
level
overtli
chang
sarscovinfect
mice
fig
therefor
specul
sarscov
might
affect
lung
patholog
test
idea
establish
defin
model
system
use
recombin
sarscov
surfacespik
protein
essenti
ligand
bind
model
system
allow
us
avoid
possibl
secondari
effect
result
viral
replic
infect
vivo
directli
test
whether
sarscov
spike
protein
might
advers
affect
acut
lung
injuri
modul
first
test
whether
recombin
sarscov
spike
protein
supplementari
fig
onlin
bind
human
well
mous
protein
use
vitro
pulldown
assay
recombin
spikefc
protein
inde
pull
human
mous
fig
sarscov
spikefc
bind
human
mous
confirm
fac
bind
assay
spikefc
cell
overexpress
human
mous
fig
moreov
spikefc
bound
endogen
vero
cell
fig
notabl
bind
spikefc
endogen
vero
cell
result
downregul
surfac
express
fig
supplementari
fig
onlin
spikefc
also
decreas
surfac
level
human
mous
overexpress
cell
data
shown
trigger
syncytia
format
mous
control
cell
shown
thu
analog
virusreceptor
interact
sarscov
spike
protein
bind
cell
line
sarscov
infect
vivo
result
reduc
protein
express
crucial
sarscov
receptor
fig
sarscov
spike
protein
bind
downmodul
express
fig
loss
express
result
sever
acut
respiratori
failur
test
whether
sarscov
spike
protein
crucial
bind
protein
could
affect
sever
acut
lung
injuri
vivo
notabl
treatment
spikefc
protein
worsen
lung
function
wildtyp
mice
wherea
controlfc
protein
show
appar
effect
fig
moreov
spikefc
treatment
acidchalleng
wildtyp
mice
augment
patholog
chang
lung
parenchyma
fig
b
c
supplementari
tabl
onlin
increas
lung
edema
defin
wetdri
lung
weight
ratio
fig
next
made
spikedelet
mutant
contain
previous
map
domain
amino
acid
fuse
human
fc
fig
supplementari
fig
onlin
short
spike
fc
protein
contain
minim
bind
site
also
bind
cell
line
use
fac
assay
downmodul
cellsurfac
express
supplementari
fig
onlin
treatment
spike
fc
worsen
acidinduc
acut
lung
injuri
wildtyp
mice
fig
notabl
vivo
spikefc
protein
administr
affect
sever
lung
failur
knockout
mice
fig
indic
effect
spike
protein
acut
lung
injuri
specif
clarifi
whether
intraperiton
inject
spikefc
protein
directli
affect
lung
patholog
mice
examin
local
inject
spikefc
protein
lung
spikefc
detect
lung
homogen
western
blot
use
human
fcspecif
antibodi
fig
wherea
inject
controlfc
detect
addit
use
immunohistochemistri
found
spikefc
protein
local
bronchial
epitheli
cell
inflammatori
exud
alveolar
pneumocyt
fig
notabl
spikefc
primarili
local
sever
lesion
fig
local
spikefc
protein
similar
spike
antigen
stain
sarscovinfect
mice
spikefc
treatment
result
downregul
protein
express
lung
acidtr
wildtyp
mice
vivo
fig
consist
protein
downregul
sarscovinfect
mice
fig
spikefc
proteintr
cell
vitro
fig
result
show
sarscov
spike
protein
directli
affect
develop
sever
acut
lung
failur
function
carboxypeptidas
cleav
singl
residu
angiotensin
angi
gener
singl
residu
angiotensin
ii
angii
gener
ref
homologu
ace
contrast
cleav
decapeptid
angi
octapeptid
angii
thu
counterbal
function
ace
neg
regul
angii
product
fig
test
whether
spikefc
inject
inde
affect
function
reninangiotensin
system
analyz
angii
level
lung
acidand
spikefctr
mice
acid
aspir
increas
angii
level
lung
wildtyp
mice
notabl
observ
signific
increas
angii
level
lung
tissu
mice
treat
spikefc
fig
confirm
whether
spikefc
promot
lung
diseas
pathogenesi
increas
angii
product
function
alter
reninangiotensin
system
block
angii
receptor
type
specif
inhibitor
crucial
receptor
mediat
angiiinduc
vascular
permeabl
sever
acut
lung
injuri
inhibit
inde
attenu
acut
sever
lung
injuri
spikefctr
mice
fig
inhibit
also
attenu
pulmonari
edema
fig
taken
togeth
data
show
sarscov
spike
exagger
acut
lung
failur
deregul
reninangiotensin
system
moreov
sarscov
spikemedi
lung
failur
rescu
inhibit
estim
spanish
flu
viru
kill
million
peopl
begin
twentieth
centuri
lethal
around
infect
peopl
wherea
lethal
sarscov
infect
reach
even
modern
intens
care
treatment
given
high
lethal
sar
enorm
econom
social
impact
worldwid
sar
outbreak
elucid
diseas
pathogenesi
crucial
futur
treatment
case
renew
outbreak
moreov
recent
outbreak
avian
influenza
human
result
lethal
acut
respiratori
failur
discoveri
sarscov
two
coronavirus
known
infect
human
caus
selflimit
upper
respiratori
tract
infect
common
cold
never
report
caus
sever
ill
molecular
determin
may
account
dramat
differ
pathogenesi
human
coronavirus
sarscov
unknown
data
provid
molecular
explan
sever
lung
failur
lethal
associ
sar
hypothes
infect
sarscov
result
downregul
bind
sarscov
spike
protein
given
key
neg
regulatori
factor
sever
lung
edema
acut
lung
failur
sarscov
spike
proteinmedi
downregul
contribut
sever
lung
patholog
scenario
would
explain
famili
member
rel
harmless
coronavirus
turn
lethal
viru
notabl
recent
data
small
cohort
individu
sar
suggest
insert
delet
ace
polymorph
affect
ace
function
correl
diseas
sever
impli
find
inde
relev
human
data
provid
molecular
link
sar
pathogenesi
role
reninangiotensin
system
lung
failur
recombin
protein
therefor
could
treatment
block
spread
sarscov
modul
reninangiotensin
system
could
also
use
protect
individu
sar
possibl
individu
infect
virus
avian
influenza
strain
develop
acut
sever
lung
failur
acut
respiratori
distress
syndrom
vivo
sar
infect
sarscov
beij
strain
isol
use
studi
provid
z
wang
liu
chines
academi
medic
scienc
chines
nation
human
genom
center
mous
studi
approv
ministri
health
scienc
technolog
divis
peopl
republ
china
intranas
inocul
mice
viru
tcid
day
mice
kill
lung
remov
analys
assess
lung
injuri
score
describ
previous
clone
code
sequenc
sarscov
spike
protein
amino
acid
urbani
strain
spike
sequenc
contain
previous
map
domain
amino
acid
gener
fusion
protein
fc
portion
angii
peptid
level
lung
spike
fc
proteinor
controlfctr
wildtyp
mice
salin
acid
aspir
angii
level
determin
h
enzym
immunoassay
bar
mean
sem
p
compar
spike
fcand
controlfctr
wildtyp
mice
acid
injuri
e
lung
elast
measur
acid
plu
spike
fcchalleng
wildtyp
mice
treat
inhibitor
losartan
mgkg
n
per
group
p
compar
losartantr
spike
fcchalleng
mice
vehicletr
spike
fcchalleng
mice
f
wet
dri
weight
ratio
lung
acid
spike
challeng
mice
presenc
absenc
losartan
mgkg
n
mice
per
group
p
compar
losartantr
wildtyp
vehicletr
wildtyp
mice
h
acid
injuri
human
purifi
spikefc
protein
transfect
cho
cell
use
affin
chromatographi
vitro
bind
assay
use
cell
lysat
human
alveolar
epitheli
cell
imcd
mous
kidney
epitheli
cell
pull
spikefc
control
human
iggfc
protein
use
protein
g
sepharos
follow
western
blot
flow
cytometri
detach
vero
cell
use
mm
mixtur
edta
pb
incub
spikefc
control
human
iggfc
protein
c
c
h
incub
cell
antibodi
fitcconjug
human
iggspecif
antibodi
recombin
spikefc
vivo
challeng
mice
use
mous
model
acid
aspirationinduc
acut
lung
injuri
spikefc
vivo
experi
mice
receiv
spike
fc
spike
fc
controlfc
nmolkg
intraperiton
three
time
min
h
acid
treatment
inhibit
spikefcmedi
acut
lung
injuri
treat
spike
fcchalleng
mice
inhibitor
losartan
mgkg
lung
injuri
score
assess
describ
previous
statist
analys
data
shown
mean
sem
measur
singl
time
point
analyz
unpair
ttest
viru
titer
sarscov
spikerna
level
anova
two
tail
ttest
percent
chang
elast
wetdri
ratio
angii
level
kruskalw
test
histolog
score
time
cours
analyz
repeat
measur
mix
model
anova
bonferroni
postt
test
statist
test
calcul
use
graphpad
prism
graphpad
softwar
jmp
sa
institut
program
p
consid
indic
statist
signific
access
number
genbank
access
number
sar
coronaviru
beij
strain
isol
note
supplementari
inform
avail
natur
medicin
websit
